Labrys Biologics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $825M

Labrys Biologics General Information

Description

Developer of preventative treatments for migraines. The company's lead candidate, LBR-101, is an anti-CGRP monoclonal antibody for the prevention og chronic and high frequency migraines.

Contact Information

Website
www.labrysbiologics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1810 Gateway Drive
  • Suite 230
  • San Mateo, CA 94404
  • United States
+1 (650)
Primary Industry
Pharmaceuticals
Acquirer
Teva Pharmaceutical Industries
Vertical(s)
Life Sciences
Corporate Office
  • 1810 Gateway Drive
  • Suite 230
  • San Mateo, CA 94404
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Labrys Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 21-Jul-2014 $825M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 03-Jan-2013 Completed Clinical Trials - Phase 2
To view Labrys Biologics’s complete valuation and funding history, request access »

Labrys Biologics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Labrys Biologics’s complete cap table history, request access »

Labrys Biologics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of preventative treatments for migraines. The company's lead candidate, LBR-101, is an anti-CGRP monoclonal an
Pharmaceuticals
San Mateo, CA

Karachi, Pakistan

Burlington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Labrys Biologics Competitors (3)

One of Labrys Biologics’s 3 competitors is Pfizer Pakistan, a Corporation company based in Karachi, Pakistan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer Pakistan Corporation Karachi, Pakistan
Cardurion Venture Capital-Backed Burlington, MA
Ability Pharma Private Equity-Backed Barcelona, Spain
You’re viewing 3 of 3 competitors. Get the full list »

Labrys Biologics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • Pending

  • Expiring in next 12 mo

Labrys Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220048986-A1 Preventing, treating, and reducing (persistent) post-traumatic headache Inactive 24-Sep-2015
US-20200148761-A1 Preventing, treating, and reducing (persistent) post-traumatic headache Inactive 24-Sep-2015
ES-2584907-T3 Methods for treating inflammatory pain Active 04-Mar-2008
ES-2433251-T3 Antagonist antibodies directed against a peptide related to the calcitonin gene and procedures using them Active 14-Nov-2005 A61K31/4045

Labrys Biologics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Canaan Partners Venture Capital Minority
InterWest Health Partners Corporate Venture Capital Minority
InterWest Partners Venture Capital Minority
Sofinnova Investments Venture Capital Minority
venBio Venture Capital Minority
To view Labrys Biologics’s complete investors history, request access »

Ready to get started?

Request a free trial

Labrys Biologics FAQs

  • When was Labrys Biologics founded?

    Labrys Biologics was founded in 2012.

  • Where is Labrys Biologics headquartered?

    Labrys Biologics is headquartered in San Mateo, CA.

  • What industry is Labrys Biologics in?

    Labrys Biologics’s primary industry is Pharmaceuticals.

  • Is Labrys Biologics a private or public company?

    Labrys Biologics is a Private company.

  • What is the current valuation of Labrys Biologics?

    The current valuation of Labrys Biologics is .

  • What is Labrys Biologics’s current revenue?

    The current revenue for Labrys Biologics is .

  • How much funding has Labrys Biologics raised over time?

    Labrys Biologics has raised $31M.

  • Who are Labrys Biologics’s investors?

    Canaan Partners, InterWest Health Partners, InterWest Partners, Sofinnova Investments, and venBio have invested in Labrys Biologics.

  • Who are Labrys Biologics’s competitors?

    Pfizer Pakistan, Cardurion, and Ability Pharma are competitors of Labrys Biologics.

  • When was Labrys Biologics acquired?

    Labrys Biologics was acquired on 21-Jul-2014.

  • Who acquired Labrys Biologics?

    Labrys Biologics was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »